Support for funding applications

EATRIS offers a range of services to help researchers strengthen the translational potential of their research proposals

What can we help with?

Click on a tile to find out more

HORIZON Europe – Health Cluster (deadline February 1st, 2022) 

Please find below the next calls of HE Heath Cluster: 

For more information, please find here the HE Work Programme 2021-2027.  

 If you need any support identifying the right consortium partners, we invite you to make use of the EATRIS consortium-building service and submit your request using this form.   

View the latest list of expertise of EATRIS member institutions for Horizon Europe calls here. EATRIS-Institutions-Expertise-for-Horizon-Europe-calls_CS.pdf

ERA PerMed – Joint Transnational Call for Proposals (2022) for “Prevention in Personalised Medicine” (deadline for pre-proposals on February 17, 2022) 

The call aims to support translational research projects in the field of Personalised Medicine, to encourage and enable interdisciplinary collaborations towards implementation of PM and to encourage collaboration between academia, clinical/public health research and SMEs. 

Each proposal MUST address at least one module out of each research area:  

  1.  “Translating Basic to Clinical Research and Beyond” (pre-clinical research-clinical research)
  2. “Data and Information and Communication Technology (ICT)” (enabling technology-toward application in healthcare)
  3. “Responsible and Effective Implementation in Healthcare” (health economics and implementation support-ethical legal and social aspects) 

The call is expected to be launched on December 1st, 2021, for more information please see here. 

The expertise of EATRIS member institutions relevant for this call includes (non -comprehensive list): 

  • Multiomics technologies, Expertise in Biomarkers, Samples/data cohorts, Radiomics, Epigenetics, novel RNA-based therapeutics
  • Large/Medium-scale analysis of proteins (Mass spectrometry; Multiplex immuno-assays)  
  • In vivo Imaging Technologies 
  • Bioinformatics and artificial Intelligence expertise 
  • Expertise in cell therapy and genome editing products in targeted cells and tissues  
  • Expertise in Regulatory Expertise for Advanced Therapies  
  • Expertise in upscaling and product development of advanced therapies  
  • Preclinical models (in vivo, in vitro, in silico)  
  • Identification of new drug targets and mechanism of action studies  
  • Development of in vivo (clinical grade) imaging probes
  • Chemosensitivity screening

If you need any support identifying the right consortium partners, we invite you to make use of the EATRIS consortium-building service and submit your request using this form. 

Fight Kids Cancer – 4 million call for proposal (Expression of Interest submission November 30th, 2021) 

The Fight Kids Cancer programme is an exciting venture founded by three European NGO’s that have joined forces to launch an opportunity to support academic research for pediatric cancers. 

This call will offer up to 4 million euros to support a number of the best research projects in clinical (will be awarded for clinical trials a maximum of 1,5 million per project) and translational research (with a maximum of 500 000 euros per project) in order to accelerate therapeutic innovation for children and adolescents with cancer. Projects are expected to propose research on either: 

  1. Early Phase Clinical Trials to evaluate innovative therapies for children and adolescents with cancer. 
  2. Translational research projects addressing childhood and adolescent cancers. 

The projects are expected to start in January 2023, the duration will be 2 years for translational projects and 3 years for clinical trial projects. 

For more information, please see here. 


Support for Funding Applications leaflet

Expertise of EATRIS member institutions for Horizon Europe calls

Strengthening your funding proposal with innovation and training

View all funding opportunities (EATRIS members only)


Interested in receiving EATRIS support?


Anne-Charlotte Fauvel
Head of EU Affairs